This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Florida Research Foundation Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Kevin R Nash: Innovator in Recombinant AAV Virion Production
Introduction
Kevin R Nash is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of biotechnology, particularly in the production of pseudotyped recombinant AAV virions. His work has implications for gene therapy and other medical applications.
Latest Patents
Kevin R Nash holds a patent for the "Production of pseudotyped recombinant AAV virions." This patent involves vectors that encode Adeno-Associated Virus (AAV) Rep and Cap proteins of different serotypes, along with Adenovirus transcription products that provide essential helper functions. The purification methods he developed generated pseudotyped rAAV virion stocks that were 99% pure, with titers of 1×10–1×10 vector genomes/ml.
Career Highlights
Kevin is affiliated with the University of Florida Research Foundation, Incorporated, where he continues to advance research in his field. His innovative approaches have positioned him as a key figure in the development of gene therapy technologies.
Collaborations
Throughout his career, Kevin has collaborated with notable colleagues, including Richard O Snyder and Sergei Zolotukhin. These partnerships have enhanced the scope and impact of his research.
Conclusion
Kevin R Nash is a distinguished inventor whose work in recombinant AAV virion production is paving the way for advancements in gene therapy. His contributions are vital to the ongoing evolution of biotechnological innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile